Neurological Disease Modeling Using Pluripotent and Multipotent Stem Cells: A Key Step towards Understanding and Treating Mucopolysaccharidoses

Detalhes bibliográficos
Autor(a) principal: Carvalho, Sofia
Data de Publicação: 2023
Outros Autores: Santos, Juliana Inês, Moreira, Luciana, Gonçalves, Mariana, David, Hugo, Matos, Liliana, Encarnação, Marisa, Alves, Sandra, Coutinho, Maria Francisca
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
Texto Completo: http://hdl.handle.net/10400.18/9125
Resumo: (This article belongs to the Special Issue Molecular Mechanisms in Lysosomal Storage Diseases: From Pathogenesis to Therapeutic Strategies 2.0)
id RCAP_c2a5b207939c2055aa43ae65982242fd
oai_identifier_str oai:repositorio.insa.pt:10400.18/9125
network_acronym_str RCAP
network_name_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository_id_str 7160
spelling Neurological Disease Modeling Using Pluripotent and Multipotent Stem Cells: A Key Step towards Understanding and Treating MucopolysaccharidosesMucopolysaccharidosesDisease ModelingIn Vvitro ModelsInduced Pluripotent Stem Cells (iPSCs)Dental Pulp Stem Cells (DPSCs)Genética HumanaDoenças Genéticas(This article belongs to the Special Issue Molecular Mechanisms in Lysosomal Storage Diseases: From Pathogenesis to Therapeutic Strategies 2.0)ReviewDespite extensive research, the links between the accumulation of glycosaminoglycans (GAGs) and the clinical features seen in patients suffering from various forms of mucopolysaccharidoses (MPSs) have yet to be further elucidated. This is particularly true for the neuropathology of these disorders; the neurological symptoms are currently incurable, even in the cases where a disease-specific therapeutic approach does exist. One of the best ways to get insights on the molecular mechanisms driving that pathogenesis is the analysis of patient-derived cells. Yet, not every patient-derived cell recapitulates relevant disease features. For the neuronopathic forms of MPSs, for example, this is particularly evident because of the obvious inability to access live neurons. This scenario changed significantly with the advent of induced pluripotent stem cell (iPSC) technologies. From then on, a series of differentiation protocols to generate neurons from iPSC was developed and extensively used for disease modeling. Currently, human iPSC and iPSC-derived cell models have been generated for several MPSs and numerous lessons were learnt from their analysis. Here we review most of those studies, not only listing the currently available MPS iPSC lines and their derived models, but also summarizing how they were generated and the major information different groups have gathered from their analyses. Finally, and taking into account that iPSC generation is a laborious/expensive protocol that holds significant limitations, we also hypothesize on a tempting alternative to establish MPS patient-derived neuronal cells in a much more expedite way, by taking advantage of the existence of a population of multipotent stem cells in human dental pulp to establish mixed neuronal and glial cultures.Funding: This work was partially supported by the Portuguese Society for Metabolic Disorders, SPDM (Bolsa SPDM de apoio à investigação Dr. Aguinaldo Cabral 2018; 2019DGH1629/SPDM2018I&D), Sanfilippo Children’s Foundation (2019DGH1656/SCF2019I&D), and Fundação para a Ciência e a Tecnologia, FCT: EXPL/BTM-SAL/0659/2021; UIDB/00211/2020—Centro de Estudos de Ciência Animal/Center for the Study of Animal Science; LA/P/0059/2020—Laboratório Associado para Ciência Animal e Veterinária/Associate Laboratory for Animal and Veterinary Sciences.MDPIRepositório Científico do Instituto Nacional de SaúdeCarvalho, SofiaSantos, Juliana InêsMoreira, LucianaGonçalves, MarianaDavid, HugoMatos, LilianaEncarnação, MarisaAlves, SandraCoutinho, Maria Francisca2024-02-19T16:07:16Z2023-04-212023-04-21T00:00:00Zinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articleapplication/pdfhttp://hdl.handle.net/10400.18/9125engBiomedicines. 2023 Apr 21;11(4):1234. doi: 10.3390/biomedicines11041234. Review2227-905910.3390/biomedicines11041234info:eu-repo/semantics/openAccessreponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãoinstacron:RCAAP2024-02-24T01:30:55Zoai:repositorio.insa.pt:10400.18/9125Portal AgregadorONGhttps://www.rcaap.pt/oai/openaireopendoar:71602024-03-20T03:11:15.601372Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãofalse
dc.title.none.fl_str_mv Neurological Disease Modeling Using Pluripotent and Multipotent Stem Cells: A Key Step towards Understanding and Treating Mucopolysaccharidoses
title Neurological Disease Modeling Using Pluripotent and Multipotent Stem Cells: A Key Step towards Understanding and Treating Mucopolysaccharidoses
spellingShingle Neurological Disease Modeling Using Pluripotent and Multipotent Stem Cells: A Key Step towards Understanding and Treating Mucopolysaccharidoses
Carvalho, Sofia
Mucopolysaccharidoses
Disease Modeling
In Vvitro Models
Induced Pluripotent Stem Cells (iPSCs)
Dental Pulp Stem Cells (DPSCs)
Genética Humana
Doenças Genéticas
title_short Neurological Disease Modeling Using Pluripotent and Multipotent Stem Cells: A Key Step towards Understanding and Treating Mucopolysaccharidoses
title_full Neurological Disease Modeling Using Pluripotent and Multipotent Stem Cells: A Key Step towards Understanding and Treating Mucopolysaccharidoses
title_fullStr Neurological Disease Modeling Using Pluripotent and Multipotent Stem Cells: A Key Step towards Understanding and Treating Mucopolysaccharidoses
title_full_unstemmed Neurological Disease Modeling Using Pluripotent and Multipotent Stem Cells: A Key Step towards Understanding and Treating Mucopolysaccharidoses
title_sort Neurological Disease Modeling Using Pluripotent and Multipotent Stem Cells: A Key Step towards Understanding and Treating Mucopolysaccharidoses
author Carvalho, Sofia
author_facet Carvalho, Sofia
Santos, Juliana Inês
Moreira, Luciana
Gonçalves, Mariana
David, Hugo
Matos, Liliana
Encarnação, Marisa
Alves, Sandra
Coutinho, Maria Francisca
author_role author
author2 Santos, Juliana Inês
Moreira, Luciana
Gonçalves, Mariana
David, Hugo
Matos, Liliana
Encarnação, Marisa
Alves, Sandra
Coutinho, Maria Francisca
author2_role author
author
author
author
author
author
author
author
dc.contributor.none.fl_str_mv Repositório Científico do Instituto Nacional de Saúde
dc.contributor.author.fl_str_mv Carvalho, Sofia
Santos, Juliana Inês
Moreira, Luciana
Gonçalves, Mariana
David, Hugo
Matos, Liliana
Encarnação, Marisa
Alves, Sandra
Coutinho, Maria Francisca
dc.subject.por.fl_str_mv Mucopolysaccharidoses
Disease Modeling
In Vvitro Models
Induced Pluripotent Stem Cells (iPSCs)
Dental Pulp Stem Cells (DPSCs)
Genética Humana
Doenças Genéticas
topic Mucopolysaccharidoses
Disease Modeling
In Vvitro Models
Induced Pluripotent Stem Cells (iPSCs)
Dental Pulp Stem Cells (DPSCs)
Genética Humana
Doenças Genéticas
description (This article belongs to the Special Issue Molecular Mechanisms in Lysosomal Storage Diseases: From Pathogenesis to Therapeutic Strategies 2.0)
publishDate 2023
dc.date.none.fl_str_mv 2023-04-21
2023-04-21T00:00:00Z
2024-02-19T16:07:16Z
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://hdl.handle.net/10400.18/9125
url http://hdl.handle.net/10400.18/9125
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv Biomedicines. 2023 Apr 21;11(4):1234. doi: 10.3390/biomedicines11041234. Review
2227-9059
10.3390/biomedicines11041234
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv MDPI
publisher.none.fl_str_mv MDPI
dc.source.none.fl_str_mv reponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron:RCAAP
instname_str Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron_str RCAAP
institution RCAAP
reponame_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
collection Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository.name.fl_str_mv Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
repository.mail.fl_str_mv
_version_ 1799137762609201152